1
|
Zhang J, Chen Y, Cheng G, Deng C, Zhao A, Ouyang F. Activation patterns and electrophysiological characteristics of Marshall Bundle related left atrial tachycardias post atrial fibrillation ablation. Heart Rhythm 2024:S1547-5271(24)03271-5. [PMID: 39214392 DOI: 10.1016/j.hrthm.2024.08.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Revised: 08/21/2024] [Accepted: 08/23/2024] [Indexed: 09/04/2024]
Abstract
BACKGROUND Epicardial Marshall bundle (MB) are frequently utilized in left atrial tachycardias (LATs) post atrial fibrillation (AF) ablation with pulmonary vein isolation and substrate modification. OBJECTIVE This study sought to classify different activation patterns of MB mediated LATs and the corresponding electrophysiological characteristics. METHODS From 2019 to 2021, 28 cases of atrial tachycardias(ATs)post-AF-ablation were diagnosed as MB-mediated LATs by ultra-high density mapping and entrainment. Cannulation and mapping in the vein of Marshall (VOM) and epicardial mapping in the MB region were also performed in selected cases to further prove the mechanism. RESULTS Three activation patterns were identified with a critical isthmus via MB: 1)peri-mitral macro-reentry (PM LAT) (n=20, 71.4%); 2) Left atrial appendage (LAA)-related reentry (n=5, 17.9%); and 3) Left pulmonary vein (LPV)-related reentry (n=3,10.7%). In 18 patients, a characteristic triple potential observed along the previously endocardial LA ridge block line was composed of near-field double potentials and far-field MB potential. These findings were further delineated in 24 patients with either cannulation in the VOM (19 patients) or epicardial mapping(5 patients). Ethanol infusion of the VOM resulted in AT termination in 20/28 patients. CONCLUSION Different types of MB-Mediated LATs post AF-ablation could be identified by ultra- high density mapping. Ethanol infusion within the VOM was effective in eliminating these tachycardias.
Collapse
Affiliation(s)
- Jinlin Zhang
- Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, 430022, China.
| | - Yanhong Chen
- Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, 430022, China
| | - Guanghui Cheng
- Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, 430022, China
| | - Chenggang Deng
- Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, 430022, China
| | | | - Feifan Ouyang
- Department of Cardiology, Heart &Vessel center, University Hospital Eppendorf, 20146 Hamburg Germany/Hongkong Asia Medical Group, Hongkong, China
| |
Collapse
|
2
|
Munawara R, Saini JK, Gupta T. Morphometry of left atrial appendage isthmus and mitral isthmus: implications for atrial fibrillation catheter ablation. J Interv Card Electrophysiol 2024:10.1007/s10840-024-01896-7. [PMID: 39093487 DOI: 10.1007/s10840-024-01896-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Accepted: 07/24/2024] [Indexed: 08/04/2024]
Abstract
BACKGROUND Radiofrequency catheter ablation (RFA) targets the left atrial appendage isthmus (LAA isthmus) and mitral isthmus for treatment of atrial fibrillation. However, proximity of left circumflex artery (LCxA) and great cardiac vein (GCV) in the isthmuses poses fatal risks during ablation. METHODS This study investigated relationships of LCxA and GCV across three lines in the LAA and mitral isthmus, using 15 human cadaveric hearts. Distances between the vessels and the endocardium, myocardium, and perivascular fat thickness were measured. RESULTS The results showed that LCxA was mostly consistently located in lower atrial segments and GCV was in lower/upper atrial segments, with change of course mainly observed in the middle of the LAA. The LCxA was found as close as 3-5 mm from the lower border of the LAA isthmus in 80% of specimens, at a depth of 2-3 mm within the LAA isthmus, where 1 mm consisted of myocardium and the remainder was fat, which may not provide adequate protection due to the possibility of liquefaction of fat with heat application. The effective myocardial thickness was consistently 1 mm across all cases in both isthmuses. LCxA was 2 mm in second and third sections of LAA isthmus ("careful segment"). LCxA distances from left inferior pulmonary vein opening was 5 to 12 mm, occasionally dangerously close as <1 mm in 16% of cases. CONCLUSION This study measured LCxA and GCV in the LAA and mitral isthmus across three lines for the first time in the Indian population, aiding surgeons in RFA planning.
Collapse
Affiliation(s)
- Rafika Munawara
- Department of Anatomy, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - Jasmine Kaur Saini
- Department of Anatomy, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - Tulika Gupta
- Department of Anatomy, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
| |
Collapse
|
3
|
Neira V, Hanson M, Tso M, Khakh P, Burak C, Alam M, Sanhueza E, Bakker D, Pardy J, Redfearn D, Chacko S, Simpson C, Abdollah H, Baranchuk A, Enriquez A. Comparison of anterior mitral line and mitral isthmus line for ablation of mitral annular flutter. J Cardiovasc Electrophysiol 2024; 35:1480-1486. [PMID: 38802972 DOI: 10.1111/jce.16325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 05/06/2024] [Accepted: 05/15/2024] [Indexed: 05/29/2024]
Abstract
BACKGROUND Mitral annular flutter (MAF) is the most common left atrial macro-reentrant arrhythmia following catheter ablation of atrial fibrillation (AF). The best ablation approach for this arrhythmia remains unclear. METHODS This single-center, retrospective study sought to compare the acute and long-term outcomes of patients with MAF treated with an anterior mitral line (AML) versus a mitral isthmus line (MIL). Acute ablation success, complication rates, and long-term arrhythmia recurrence were compared between the two groups. RESULTS Between 2015 and 2021, a total of 81 patients underwent ablation of MAF (58 with an AML and 23 with a MIL). Acute procedural success defined as bidirectional block was achieved in 88% of the AML and 91% of the MIL patients respectively (p = 1.0). One year freedom from atrial arrhythmias was 49.5% versus 77.5% and at 4 years was 24% versus 59.6% for AML versus MIL, respectively (hazard ratio [HR]: 0.38, confidence interval [CI]: 0.17-0.82, p = .009). Fewer patients in the MIL group had recurrent atrial flutter when compared to the AML group (HR: 0.32, CI: 0.12-0.83, p = .009). The incidence of recurrent AF, on the other side, was not different between both groups (21.7% vs. 18.9%; p = .76). There were no serious adverse events in either group. CONCLUSION In this retrospective study of patients with MAF, a MIL compared to AML was associated with a long-term reduction in recurrent atrial arrhythmias driven by a reduction in macroreentrant atrial flutters.
Collapse
Affiliation(s)
- Victor Neira
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Matthew Hanson
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Melissa Tso
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Parm Khakh
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Cengiz Burak
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Maqsood Alam
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Eduardo Sanhueza
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - David Bakker
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Jacob Pardy
- Abbott Medical, Mississauga, Ontario, Canada
| | - Damian Redfearn
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Sanoj Chacko
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | | | - Hoshiar Abdollah
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Adrian Baranchuk
- Division of Cardiology, Queen's University, Kingston, Ontario, Canada
| | - Andres Enriquez
- Section of Cardiac Electrophysiology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
4
|
O’Neill L, De Becker B, De Smet M, Francois C, Tavernier R, Duytschaever M, Le Polain De Waroux JB, Knecht S. Vein of Marshall Ethanol Infusion for AF Ablation; A Review. J Clin Med 2024; 13:2438. [PMID: 38673710 PMCID: PMC11050818 DOI: 10.3390/jcm13082438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 04/14/2024] [Accepted: 04/17/2024] [Indexed: 04/28/2024] Open
Abstract
The outcomes of persistent atrial fibrillation (AF) ablation are modest with various adjunctive strategies beyond pulmonary vein isolation (PVI) yielding largely disappointing results in randomised controlled trials. Linear ablation is a commonly employed adjunct strategy but is limited by difficulty in achieving durable bidirectional block, particularly at the mitral isthmus. Epicardial connections play a role in AF initiation and perpetuation. The ligament of Marshall has been implicated as a source of AF triggers and is known to harbour sympathetic and parasympathetic nerve fibres that contribute to AF perpetuation. Ethanol infusion into the Vein of Marshall, a remnant of the superior vena cava and key component of the ligament of Marshall, may eliminate these AF triggers and can facilitate the ease of obtaining durable mitral isthmus block. While early trials have demonstrated the potential of Vein of Marshall 'ethanolisation' to reduce arrhythmia recurrence after persistent AF ablation, further randomised trials are needed to fully determine the potential long-term outcome benefits afforded by this technique.
Collapse
Affiliation(s)
- Louisa O’Neill
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
- Department of Cardiology, Blackrock Clinic, A94 E4X7 Dublin, Ireland
- King’s College London, St. Thomas’ Hospital, London SE1 9NH, UK
| | - Benjamin De Becker
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| | - Maarten De Smet
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| | - Clara Francois
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| | - Rene Tavernier
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| | - Mattias Duytschaever
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| | | | - Sebastien Knecht
- Department of Cardiology, AZ Sint-Jan Hospital, 8000 Bruges, Belgium; (B.D.B.); (S.K.)
| |
Collapse
|
5
|
Mechulan A, Dieuzaide P, Peret A, Vaugrenard T, Houamria S, Pons F, Nait-Saidi L, Miliani I, Lemann T, Bouharaoua A, Prévot S. Strategy to achieve mitral isthmus flutter ablation by radiofrequency: the SHERIFF plan. J Interv Card Electrophysiol 2024:10.1007/s10840-024-01804-z. [PMID: 38602601 DOI: 10.1007/s10840-024-01804-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Accepted: 03/31/2024] [Indexed: 04/12/2024]
Abstract
BACKGROUND Achieving mitral isthmus (MI) block can be challenging. This prospective study evaluated the feasibility and efficacy of a systematic strategy comprising three consecutive steps to achieve MI block. METHODS Twenty consecutive patients (mean (± SD) age 71.4 ± 6.98 years) undergoing ablation of perimitral atrial tachycardia (PMAT) between December 2019 and November 2021 were included. MI was ablated using a systematic strategy comprising up to three consecutive steps: (1) endocardial ablation from the superolateral mitral annulus to the left pulmonary veins; (2) additional epicardial ablation in the coronary sinus (CS) on the opposite side of the endocardial line; and (3) ablation of early activation sites between endocardial and epicardial breakthroughs. RESULTS MI block was successfully achieved in 19/20 patients (95%). MI block after endocardial radiofrequency ablation alone (step 1) was observed in 7/20 patients (35%). Epicardial ablation within the CS on the other side of the endocardial line (step 2) resulted in bidirectional MI block in three more patients. Endocardial ablation of epicardial conduction was successful for nine additional patients (95% success). At the 12-month follow-up, five patients (25%) displayed recurrence of arrhythmia after a single procedure. One patient had electrical cardioversion for persistent atrial fibrillation. Four patients had a redo procedure for left atrial flutter and only two patients (10%) had conduction across the MI and showed recurrence of PMAT. No complications occurred. CONCLUSIONS The three-step ablation strategy resulted in a high rate of acute and durable MI block. PMAT recurrence after a single procedure was 10% at 1-year follow-up.
Collapse
Affiliation(s)
- Alexis Mechulan
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France.
| | - Pierre Dieuzaide
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Angélique Peret
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Thibaud Vaugrenard
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Sophiane Houamria
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Frederic Pons
- Service de Cardiologie, Hôpital d'Instruction Des Armées Sainte-Anne, Boulevard Sainte-Anne, Toulon, France
| | - Lyassine Nait-Saidi
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Ichem Miliani
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Thomas Lemann
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Ahmed Bouharaoua
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| | - Sébastien Prévot
- Ramsay Santé, Hôpital Privé Clairval, Service Cardiologie-Rythmologie, Marseille, France
| |
Collapse
|
6
|
Ge WL, Lu YF, Li T, Wang Y, Yin J, Li XR, Jiang JJ, Mi YF, Tung TH, Yan SH. Clinical effect of vein of Marshall ethanol infusion on mitral isthmus ablation. Front Cardiovasc Med 2024; 11:1253554. [PMID: 38374993 PMCID: PMC10875083 DOI: 10.3389/fcvm.2024.1253554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Accepted: 01/08/2024] [Indexed: 02/21/2024] Open
Abstract
Purpose This study aimed to investigate the effect of Marshall ethanol infusion (VOM-Et) in the vein on mitral isthmus (MI) ablation. Methods Patients with persistent atrial fibrillation (AF) were grouped into vein of VOM-Et combined with radiofrequency (RF) ablation (VOM-Et-RF) and RF groups. The primary outcome was MI block immediate block rate after surgery. Stratified analysis was also performed for factors affecting the outcome measures. Results A total of 118 consecutive patients underwent AF ablation at Taizhou Hospital of Zhejiang Province from January 2018 to December 2021. Successful bidirectional perimitral block was achieved in 96% of patients in VOM-Et-RF (69 of 72) and in 76% of patients in the RF group (35 of 46) (P < 0.01). In the subgroup analysis, male sex, elder than 60 years, Left atrial diameter <55 mm, and AF duration <3 years were associated with the benefits of VOM-Et in AF Patients. Conclusion The vein of Marshall ethanol infusion for catheter ablation can improve the MI block rate. Male sex, elder age, smaller Left atrial diameter and shorter AF duration may have significant benefits for VOM-Et.
Collapse
Affiliation(s)
- Wei-Li Ge
- Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China
- Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China
| | - Yi-Fei Lu
- Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China
| | - Tao Li
- Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China
| | - Ye Wang
- Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Jie Yin
- Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Xin-Ran Li
- Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Jinan, China
| | - Jian-Jun Jiang
- Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China
| | - Ya-Fei Mi
- Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China
| | - Tao-Hsin Tung
- Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China
- Key Laboratory of Evidence-Based Radiology of Taizhou, Linhai, Zhejiang, China
| | - Su-Hua Yan
- Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China
- Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Jinan, China
| |
Collapse
|
7
|
Lim MW, Kistler PM. Managing peri-mitral flutter. J Cardiovasc Electrophysiol 2023; 34:2145-2151. [PMID: 36598419 DOI: 10.1111/jce.15808] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 12/15/2022] [Accepted: 12/18/2022] [Indexed: 01/05/2023]
Abstract
The exponential rise in the incidence of peri-mitral flutter has paralleled the increasing use of more extensive atrial substrate ablation for atrial fibrillation (AF). Given the relative paucity of randomized evidence to support its role in AF management, mitral isthmus ablation should largely be reserved for patients with peri-mitral flutter. Catheter ablation for peri-mitral flutter is challenging due to complex anatomic relationships. The aim of this report is to review the anatomic considerations and approaches to catheter ablation for peri-mitral flutter.
Collapse
Affiliation(s)
- Michael W Lim
- Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia
- Clinical Electrophysiology Laboratory, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
- Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - Peter M Kistler
- Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia
- Clinical Electrophysiology Laboratory, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Medicine, Monash University, Melbourne, Victoria, Australia
| |
Collapse
|
8
|
Yu SD, Chu YP. Identification of the dominant loop of a dual-loop macro-reentry left atrial flutter without prior intervention using high-density mapping technology: A case report. World J Clin Cases 2023; 11:6165-6169. [PMID: 37731554 PMCID: PMC10507564 DOI: 10.12998/wjcc.v11.i26.6165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Revised: 07/31/2023] [Accepted: 08/11/2023] [Indexed: 09/08/2023] Open
Abstract
BACKGROUND Left atrial flutter without prior cardiac interventions is uncommon, especially dual-loop macro-reentry atrial flutter. The critical step to ablate dual-loop macro-reentry atrial flutter is to identify the dominant loop and key isthmus. Although entrainment mapping could help identify the dominant loop and key isthmus, it may alter or terminate tachycardia. High-density mapping allows the generation of electroanatomic maps without altering or terminating tachycardia. CASE SUMMARY Here, we report a case of symptomatic left atrial flutter without prior intervention. In this case, high-density mapping revealed a dual-loop macro-reentry around the mitral annulus and central scar of the anterior wall. The propagation result showed that the dominant loop was around the mitral annulus, and the key isthmus was between the central scar and mitral annulus. The atrial flutter terminated successfully after ablation was performed. CONCLUSION In this case, we demonstrate that high-density mapping technology may help identify the dominant loop of dual-loop atrial flutter without entrainment, which makes ablation easier.
Collapse
Affiliation(s)
- Shan-Dong Yu
- Department of Cardiology, Capital Medical University affiliated Beijing Friendship Hospital, Beijing 100010, China
| | - Yan-Peng Chu
- Department of Cardiology, Dazhou Central Hospital, Dazhou 635000, Sichuan Province, China
| |
Collapse
|
9
|
Li J, Cui S, Song H, Cui L, Yu H, Chu Y, Dong S. A novel stepwise catheter ablation method of the mitral isthmus for persistent atrial fibrillation: efficacy and reproducibility. BMC Cardiovasc Disord 2023; 23:466. [PMID: 37715135 PMCID: PMC10504774 DOI: 10.1186/s12872-023-03490-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 09/01/2023] [Indexed: 09/17/2023] Open
Abstract
BACKGROUND Ethanol infusion of the vein of Marshall (EI-VOM) has been widely used to facilitate mitral isthmus (MI) ablation. According to the literature, the success rate of achieving a bidirectional conduction block across the MI ranges from 51 to 96%, with no standardized strategy or method available for cardiac electrophysiologists. OBJECTIVES This study aimed to introduce and evaluate a novel ablation method of MI. METHODS Consecutive patients with persistent atrial fibrillation (PeAF) that underwent catheter ablation were included. The MI ablation procedure followed a stepwise approach. In step 1, ethanol infusion of the vein of Marshall (EI-VOM) was performed. In step 2, a "V-shape" endocardial linear ablation connecting the left inferior pulmonary vein (LIPV) to mitral annulus (MA) was performed. In step 3, earliest activation sites(EASs) near the ablation line were identified using activation mapping followed by reinforced ablation. In step 4, precise epicardial ablation was performed, with the catheter introduced into the coronary sinus(CS) to target key ablation targets (KATs). RESULTS 135 patients with PeAF underwent catheter ablation with the stepwise ablation method adopted in 119 cases. Bidirectional conduction blocks were achieved in 117 patients (98.3%). The block rates of every step were 0%, 58.0%, 44.0%, and 92.9%, and the cumulative block rates for the four steps were 0%, 58.0%, 76.5%, and 98.3%, respectively. No patient experienced fatal complications. CONCLUSIONS Our novel stepwise catheter ablation method for MI yielded a high bidirectional block rate with high reproducibility.
Collapse
Affiliation(s)
- Jingchao Li
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Shihua Cui
- Dalian Medical University, Dalian, China
| | - Huihui Song
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Luqian Cui
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Haijia Yu
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China
| | - Yingjie Chu
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China.
| | - Shujuan Dong
- Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou, China.
| |
Collapse
|
10
|
Rottner L, My I, Schleberger R, Moser F, Moser J, Kirchhof P, Ouyang F, Rillig A, Metzner A, Reissmann B. Temperature-controlled ablation of the mitral isthmus line using the novel DiamondTemp ablation system. Front Cardiovasc Med 2022; 9:1046956. [PMID: 36505349 PMCID: PMC9729688 DOI: 10.3389/fcvm.2022.1046956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Accepted: 11/08/2022] [Indexed: 11/25/2022] Open
Abstract
Background The novel DiamondTemp™ (DT)-catheter (Medtronic®) was designed for high-power, short-duration ablation in a temperature-controlled mode. Aim To evaluate the performance of the DT-catheter for ablation of the mitral isthmus line (MIL) using two different energy dosing strategies. Materials and methods Twenty patients with recurrence of atrial fibrillation (AF) and/or atrial tachycardia (AT) following pulmonary vein (PV) isolation were included. All patients underwent reisolation of PVs in case of electrical reconnection and ablation of a MIL using the DT-catheter. Application durations of 10 (group A, n = 10) or 20 s (group B, n = 10) were applied. If bidirectional block was not reached with endocardial ablation, additional ablation from within the coronary sinus (CS) was conducted. Results In 19/20 (95%) patients, DT ablation of the MIL resulted in bidirectional block. Mean procedure and fluoroscopy time, and dose area product did not differ significantly between the two groups. In group B, fewer radiofrequency applications were needed to achieve bidirectional block of the MIL when compared to group A (26 ± 12 vs. 42 ± 17, p = 0.04). Ablation from within the CS was performed in 8/10 patients (80%) of group A and in 5/10 (50%) patients of group B (p = 0.34). No major complication occurred. Conclusion Mitral isthmus line ablation with use of the DT-catheter is highly effective and safe. Longer radiofrequency-applications appear to be favorable without compromising safety.
Collapse
Affiliation(s)
- Laura Rottner
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Ilaria My
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Ruben Schleberger
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Fabian Moser
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Julia Moser
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Paulus Kirchhof
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Hamburg, Germany
| | - Feifan Ouyang
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| | - Andreas Rillig
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Hamburg, Germany
| | - Andreas Metzner
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Hamburg, Germany
| | - Bruno Reissmann
- Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
| |
Collapse
|
11
|
Gillis K, O'Neill L, Wielandts JY, Hilfiker G, Almorad A, Lycke M, El Haddad M, le Polain de Waroux JB, Tavernier R, Duytschaever M, Knecht S. Vein of Marshall Ethanol Infusion as First Step for Mitral Isthmus Linear Ablation. JACC Clin Electrophysiol 2022; 8:367-376. [PMID: 35331432 DOI: 10.1016/j.jacep.2021.11.019] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Revised: 11/22/2021] [Accepted: 11/22/2021] [Indexed: 11/20/2022]
Abstract
OBJECTIVES In this study, the authors sought to investigate the added value of vein of Marshall ethanol infusion (VOMEt) as first step in facilitating radiofrequency (RF)-guided mitral isthmus (MI) block. BACKGROUND Achieving MI block with the use of RF ablation is challenging. METHODS Seventy patients planned for MI ablation were randomized 1:1 to VOMEt as a first step preceding RF (endocardial and epicardial, VOMFIRST group) vs RF ablation as a first step preceding VOMEt (RFFIRST group). The study end point was incidence of MI block after RF ablation and after the 2 steps. RESULTS In VOMFIRST, VOMEt was successful in 30/35 patients (86%) resulting in a low-voltage area of 12 ± 7.4 cm2 and MI block in 2/35 patients (6%). VOMFIRST, compared with RFFIRST, was associated with higher incidence of MI block after endocardial (46% vs 11%; P < 0.001) and epicardial ablation (94% vs 43%; P < 0.001), with fewer endocardial applications (4 vs 11 vs 4; P < 0.001) and similar epicardial applications (7 vs 8; P = 0.68). Incidence of MI block after the 2 steps was 94% vs 63% (P = 0.001) in VOMFIRST vs RFFIRST, respectively. Additional touch-up RF ablation in both groups resulted in final MI block in all but 1 patient (99%). CONCLUSIONS VOMEt as a first step in RF-guided MI line ablation significantly reduced the number of RF applications needed to achieve MI block, even if the sequence of the ablation steps did not affect the final incidence of block. (Evaluation of Vein of Marshall Ethanol Infusion During Left Atrial Linear Ablation in Patients With Persistent Atrial Fibrillation [MARSHALINE]; NCT04124328).
Collapse
Affiliation(s)
- Kris Gillis
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium.
| | - Louisa O'Neill
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | | | - Gabriela Hilfiker
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | - Alexandre Almorad
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | - Michelle Lycke
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | - Milad El Haddad
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | | | - Rene Tavernier
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| | | | - Sebastien Knecht
- Department of Cardiology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium
| |
Collapse
|
12
|
Oh S, Joo YH, Lee E, Lee SR, Cha MJ, Choi EK, Lee JC, Lee W. Left atrial wall thickness and its relationship with reconnection after pulmonary vein isolation in patients with atrial fibrillation evaluated using a three-dimensional wall thickness map. INTERNATIONAL JOURNAL OF ARRHYTHMIA 2021. [DOI: 10.1186/s42444-021-00046-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
The major cause of recurrence after pulmonary vein (PV) isolation for atrial fibrillation (AF) is PV reconnection, and thicker wall could be associated with reconnection.
Objectives
This study aimed to evaluate the wall thickness of the PV antrum in reconnection sites using a three-dimensional (3D) wall thickness map.
Methods
A total of 91 patients who underwent a second ablation procedure due to AF recurrence were evaluated. The locations of the PV reconnection sites were confirmed in electroanatomical maps. A 3D atrial wall thickness (AWT) map was created using computed tomography scan data. The AWT values of the ablation lines of the index procedure were graded in each segment of the PV antrum: grade 1, 0.5 < AWT ≤ 1.0 mm; grade 2, 1.0 < AWT ≤ 1.5 mm; grade 3, 1.5 < AWT ≤ 2.0 mm; grade 4, 2.0 < AWT ≤ 2.5 mm; grade 5, AWT > 2.5 mm.
Results
A total of 281 PV reconnection sites among 1256 segments of the PV antrum in 79 patients were detected. The average AWT grades were 2.7 ± 1.0 and 2.2 ± 1.0 in the reconnected and non-reconnected segments, respectively (P < 0.01). Higher AWT grades were observed in the reconnected superior segments of the left superior PV, carina and inferior segments of the left inferior PV, superior and posterior segments of the right superior PV, and posterior and inferior segments of the right inferior PV.
Conclusion
The reconnected segments of the PV antrum showed thicker myocardium than the non-reconnected ones in patients with recurrent AF after catheter ablation. A wall thickness map for PV isolation could be considered for customized ablation in order to reduce PV reconnection.
Collapse
|
13
|
Verma A, Asivatham SJ, Deneke T, Castellvi Q, Neal RE. Primer on Pulsed Electrical Field Ablation: Understanding the Benefits and Limitations. Circ Arrhythm Electrophysiol 2021; 14:e010086. [PMID: 34538095 DOI: 10.1161/circep.121.010086] [Citation(s) in RCA: 69] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Pulsed electrical field (PEF) energy is a promising technique for catheter ablation of cardiac arrhythmias. In this article, the key aspects that need to be considered for safe and effective PEF delivery are reviewed, and their impact on clinical feasibility is discussed. The most important benefit of PEF appears to be the ability to kill cells through mechanisms that do not alter stromal proteins, sparing sensitive structures to improve safety, without sacrificing cardiomyocyte ablation efficacy. Many parameters affect PEF treatment outcomes, including pulse intensity, waveform shape, and number of pulses, as well as electrode configuration and geometry. These physical and electrical characteristics must be titrated carefully to balance target tissue effects with collateral implications (muscle contraction, temperature rise, risk of electrical arcing events). It is important to note that any combination of parameters affecting PEF needs to be tested for clinical efficacy and safety. Applying PEF clinically requires knowledge of the fundamentals of this technology to exploit its opportunities and generate viable, durable health improvements for patients.
Collapse
Affiliation(s)
- Atul Verma
- Division of Cardiology, Southlake Regional Health Center, University of Toronto, Newmarket, Canada (A.V.)
| | - Samuel J Asivatham
- Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.J.A.)
| | - Thomas Deneke
- Division of Cardiology, Rhon-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany (T.D.)
| | | | | |
Collapse
|
14
|
Laredo M, Ferchaud V, Thomas O, Moubarak G, Cauchemez B, Zhao A. Durability of Left Atrial Lesions After Ethanol Infusion in the Vein of Marshall. JACC Clin Electrophysiol 2021; 8:41-48. [PMID: 34454885 DOI: 10.1016/j.jacep.2021.06.019] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Revised: 06/21/2021] [Accepted: 06/22/2021] [Indexed: 11/25/2022]
Abstract
OBJECTIVES The aim of this study was to assess the persistence of left atrial (LA) lesions created by ethanol infusion in the vein of Marshall (EIVM) by electroanatomical mapping on repeat catheter ablation for recurrent atrial tachyarrhythmia. BACKGROUND Little is known about the durability of LA lesions created by EIVM. METHODS The study included consecutive patients who underwent EIVM for persistent atrial fibrillation or perimitral LA flutter (index procedure) and repeat catheter ablation for recurrent atrial tachyarrhythmia or atrial fibrillation at a single center between January 2019 and April 2020. The acute effect of EIVM was assessed at the index procedure by comparing the area of bipolar voltage <0.05 mV in the vein of Marshall (VOM) region before and immediately after EIVM. The long-term effect of EIVM was assessed by comparing this area in the VOM region between the redo procedure and the index procedure. RESULTS Twenty-four consecutive patients (mean age 68.6 ± 6.1 years, 58% men) underwent redo procedures after previous EIVM for persistent atrial fibrillation (n = 21 [88%]) or perimitral LA flutter (n = 5 [21%]). In each patient, the EIVM-related lesion persisted, with a chronic scar in the VOM region (median 13.1 cm2 [interquartile range: 8.1-15.9 cm2] vs 12.4 cm2 [interquartile range: 7.6-15.7 cm2] acutely, respectively). One quarter of patients (9 of 20) had late mitral isthmus reconnection, which was located at the mitral annular edge or in the coronary sinus. CONCLUSIONS Atrial lesions created by EIVM are durable, which reinforces the efficacy profile of EIVM. Reconduction sites in the mitral isthmus are located at the edge of the scar and in the coronary sinus.
Collapse
Affiliation(s)
- Mikael Laredo
- Laboratoire d'Electrophysiologie, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Unité de Rythmologie, Institut de Cardiologie, Paris, France
| | - Virginie Ferchaud
- Centre d'Explorations de Réanimation et d'Intervention Cardiaque, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Service de Cardiologie, CHU Caen Normandie, Caen, France
| | - Olivier Thomas
- Laboratoire d'Electrophysiologie, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Centre d'Explorations de Réanimation et d'Intervention Cardiaque, Clinique Ambroise Paré, Neuilly-sur-Seine, France
| | - Ghassan Moubarak
- Laboratoire d'Electrophysiologie, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Centre d'Explorations de Réanimation et d'Intervention Cardiaque, Clinique Ambroise Paré, Neuilly-sur-Seine, France
| | - Bruno Cauchemez
- Laboratoire d'Electrophysiologie, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Centre d'Explorations de Réanimation et d'Intervention Cardiaque, Clinique Ambroise Paré, Neuilly-sur-Seine, France
| | - Alexandre Zhao
- Laboratoire d'Electrophysiologie, Clinique Ambroise Paré, Neuilly-sur-Seine, France; Centre d'Explorations de Réanimation et d'Intervention Cardiaque, Clinique Ambroise Paré, Neuilly-sur-Seine, France.
| |
Collapse
|
15
|
Dudkiewicz D, Słodowska K, Jasińska KA, Dobrzynski H, Hołda MK. The clinical anatomy of the left atrial structures used as landmarks in ablation of arrhythmogenic substrates and cardiac invasive procedures. TRANSLATIONAL RESEARCH IN ANATOMY 2021. [DOI: 10.1016/j.tria.2020.100102] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
16
|
An improved window of interest for electroanatomical mapping of atrial tachycardia. J Interv Card Electrophysiol 2021; 63:29-37. [PMID: 33506319 PMCID: PMC8755667 DOI: 10.1007/s10840-021-00940-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Accepted: 01/04/2021] [Indexed: 10/31/2022]
Abstract
PURPOSE Diagnosis of atrial tachycardia (AT) with 3D mapping system remains challenging due to fibrosis or previous ablation. This study aims to evaluate a new electroanatomical mapping annotation setting using a window of interest adjusted at the end of the P wave (WOIp wave) to identify the AT mechanism more accurately. METHODS Twenty patients with successful ablation of left AT using navigation system CARTO3 were evaluated. Two maps for each patient were generated offline using either conventional settings of WOI (WOIconv.) or WOIp wave. Three investigators from two centres analysed the maps blindly. RESULTS Mechanisms of AT were macroreentrant in 14/20 patients (70%) and focal in 6/20 (30%). WOIp wave resulted in a significant increase in the percentage of correct identification of the mechanism based on mapping alone (93.3 ± 13.7% vs 58.3 ± 33.9%; p = 0.0003) compared with WOIconv.. Diagnoses based on mapping were arrived at faster (27.8 ± 16.4 s vs 38.97 ± 13.64 s, respectively; p = 0.0231) and with a greater confidence in the diagnosis (confidence index 2.57 ± 0.45 vs 2.12 ± 0.45, respectively; p = 0.0024). With perimitral re-entry specifically "early meets late" was closer to the anatomical region of the mitral isthmus (15.9 ± 20.9 mm vs 48.77 ± 23.23 mm, respectively; p = 0.0028). CONCLUSIONS This study found that electroanatomical mapping acquisition with a window of interest set at the end of the P wave improves the ability to diagnose the arrhythmia mechanism based on the initial map. It is particularly beneficial in identifying area of interest for ablation in perimitral AT.
Collapse
|
17
|
Nakashima T, Pambrun T, Vlachos K, Goujeau C, André C, Krisai P, Ramirez FD, Kamakura T, Takagi T, Nakatani Y, Kitamura T, Takigawa M, Roux JR, Cheniti G, Tixier R, Chauvel R, Welte N, Duchateau J, Sacher F, Cochet H, Hocini M, Haïssaguerre M, Jaïs P, Derval N. Impact of Vein of Marshall Ethanol Infusion on Mitral Isthmus Block: Efficacy and Durability. Circ Arrhythm Electrophysiol 2020; 13:e008884. [PMID: 33197321 DOI: 10.1161/circep.120.008884] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Achieving bidirectional mitral isthmus (MI) block using radiofrequency catheter ablation (RFCA) alone is challenging, and MI reconnection is common. Adjunctive vein of Marshall (VOM) ethanol infusion (VOM-Et) can facilitate acute MI block. However, little is known about its long-term success. This study sought to evaluate the impact of adjunctive VOM-Et on MI block achievement and durability compared with RFCA alone. METHODS Patients undergoing the first attempt of posterior MI ablation were grouped according to their MI block index strategy: adjunctive VOM-Et and RFCA alone. Rates of acute MI block and MI reconnection observed during repeat procedures were compared between the 2 groups. RESULTS The VOM-Et group consisted of 152 patients (63.8±9.4 years) undergoing adjunctive VOM-Et for MI block. The RFCA group consisted of 110 patients (60.9±9.2 years) undergoing MI ablation using RFCA alone. Acute MI block was more frequently achieved in the VOM-Et group (98.7% [150/152] versus 63.6% [70/110]; P<0.001) with shorter RFCA duration (5.00 [3.00-7.00] versus 19.0 [13.6-22.0] minutes; P<0.001). Of the 220 patients with MI block achieved during the index procedure, 81 underwent a repeat procedure during follow-up (VOM-Et group: 23.3% [35/150] versus RFCA group: 65.7% [46/70], respectively; P<0.001). A significantly greater number of patients exhibited durable MI block in the VOM-Et group (62.9% [22/35] versus 32.6% [15/46], respectively; P=0.008). CONCLUSIONS Beyond facilitating acute MI block, VOM-Et is associated with greater lesion durability as evidenced by higher rates of MI block during repeat procedures.
Collapse
Affiliation(s)
- Takashi Nakashima
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Thomas Pambrun
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Konstantinos Vlachos
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Cyril Goujeau
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Clémentine André
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Philipp Krisai
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - F Daniel Ramirez
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Tsukasa Kamakura
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Takamitsu Takagi
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Yosuke Nakatani
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Takeshi Kitamura
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Masateru Takigawa
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | | | - Ghassen Cheniti
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Romain Tixier
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Remi Chauvel
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Nicolas Welte
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Josselin Duchateau
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Frédéric Sacher
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Hubert Cochet
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Mélèze Hocini
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Michel Haïssaguerre
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Pierre Jaïs
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| | - Nicolas Derval
- Bordeaux University Hospital (CHU), Cardiac Electrophysiology and Cardiac Stimulation Team, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (T.N., T.P., K.V., C.G., C.A., P.K., F.D.R., T. Kamakura, T.T., Y.N., T. Kitamura, M.T., G.C., R.T., R.C., N.W., J.D., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J., N.D.)
| |
Collapse
|
18
|
Sang C, Lai Y, Long D, Li M, Bai R, Jiang C, Wang W, Li S, Tang R, Guo X, Liu N, Zhao X, Zuo S, Wen S, Ning M, Wu J, Du X, Dong J, Ma C. Ethanol infusion into the vein of Marshall for recurrent perimitral atrial tachycardia after catheter ablation for persistent atrial fibrillation. PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2020; 44:773-781. [PMID: 32856303 DOI: 10.1111/pace.14052] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 08/05/2020] [Accepted: 08/14/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Caihua Sang
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Yiwei Lai
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Deyong Long
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Mengmeng Li
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Rong Bai
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Chenxi Jiang
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Wei Wang
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Songnan Li
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Ribo Tang
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Xueyuan Guo
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Nian Liu
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Xin Zhao
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Song Zuo
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Songnan Wen
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Man Ning
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Jiahui Wu
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Xin Du
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Jianzeng Dong
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| | - Changsheng Ma
- Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine for Cardiovascular Diseases Capital Medical University Beijing China
| |
Collapse
|
19
|
Massoullié G, Moubarak G, Thomas O, Da Costa A, Roger V, Justo J, Mechulan A, Eschalier R, Silberbauer J, Andronache M. Initial multicenter experience with a new high-density coloring module: impact for complex atrial arrhythmias interpretation. J Interv Card Electrophysiol 2020; 60:313-319. [PMID: 32621214 DOI: 10.1007/s10840-020-00802-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 06/15/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND High-density automated mapping of complex atrial tachycardias (ATs) requires accurate assessment of activation maps. A new local activation display module (HD coloring, Biosense Webster®) provides higher map resolution, a better delineation of potential block reducing color interpolation, and a new propagation display. We evaluated the accuracy of a dedicated local activation display compared with standard algorithm. METHODS High-density maps from 10 AT were collected with a multipolar catheter and were displayed with standard activation or HD coloring. Six expert operators retrospectively analyzed activation maps and were asked to define (1) the tachycardia mechanism, (2) ablation target, and (3) level of difficulty to interpret those maps. RESULTS Using HD coloring, operators were able to reach a correct diagnosis in 93% vs. 63%, p < 0.05 compared to standard activation maps. Time to diagnosis was shorter 1.9 ± 1.0 min vs. 3.9 ± 2.1 min, p < 0.05. Confidence level would have allowed ablation without necessity for entrainment maneuvers in 87% vs. 53%, p < 0.05. Operators would have needed to remap or proceed with multiple entrainments in 3% vs. 13% of cases, p < 0.05. Finally, ablation strategy was more accurately identified in 97% vs. 67%, p < 0.05. CONCLUSION Activation mapping with the new HD coloring module allowed a more accurate, reliable, and faster interpretation of complex ATs mechanisms compared to standard activation maps.
Collapse
Affiliation(s)
- Grégoire Massoullié
- Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France.
| | - Ghassan Moubarak
- Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France
| | - Olivier Thomas
- Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France
| | - Antoine Da Costa
- Division of Cardiology, Jean Monnet University, Saint-Etienne, France
| | | | | | | | - Romain Eschalier
- Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France
| | | | - Marius Andronache
- Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France
| |
Collapse
|
20
|
Jaïs P, Ramirez FD. A Bigger Thermal Footprint. JACC Clin Electrophysiol 2020; 6:520-522. [DOI: 10.1016/j.jacep.2020.02.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Revised: 01/31/2020] [Accepted: 02/04/2020] [Indexed: 12/25/2022]
|
21
|
Takigawa M, Derval N, Martin CA, Vlachos K, Denis A, Nakatani Y, Kitamura T, Cheniti G, Bourier F, Lam A, Martin R, Frontera A, Thompson N, Massoullié G, Wolf M, Escande W, André C, Zeng LJ, Roux JR, Duchateau J, Pambrun T, Sacher F, Cochet H, Hocini M, Haïssaguerre M, Jaïs P. Mechanism of Recurrence of Atrial Tachycardia. Circ Arrhythm Electrophysiol 2020; 13:e007273. [PMID: 31937120 DOI: 10.1161/circep.119.007273] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background:
Atrial fibrillation ablation–related atrial tachycardia (AT) is complex and may demonstrate several forms: anatomic macroreentrant AT (AMAT), non-AMAT, and focal AT. We aimed to elucidate the recurrence rate and mechanisms of atrial fibrillation ablation–related AT recurrence.
Methods:
Among 147 patients with ATs treated with the Rhythmia system, 68 (46.3%) had recurrence at mean 4.2 (2.9–11.6) months, and 44 patients received a redo procedure. AT circuits in the first procedure were compared with those in the redo procedure.
Results:
Although mappable ATs were not observed in 7 patients, 68 ATs were observed in 37 patients during the first procedure: perimitral flutter (PMF) in 26 patients, roof-dependent macroreentrant AT (RMAT) in 18, peritricuspid flutter in 10, non-AMAT in 14, and focal AT in 3. During the redo AT ablation procedure, 54 ATs were observed in 41/44 patients: PMF in 24, RMAT in 14, peritricuspid flutter in 1, non-AMAT in 14, and focal AT in 1. Recurrence of PMF and RMAT was observed in 15 of 26 (57.7%) and 8 of 18 (44.4%) patients, respectively, while peritricuspid flutter did not recur. Neither the same focal AT nor the same non-AMAT were observed except in 1 case with septal scar–related biatrial AT. Epicardial structure–related ATs were involved in 18 of 24 (75.0%) patients in PMF, 4 of 14 (28.6%) in RMAT, and 4 of 14 (28.6%) in non-AMAT. Of 21 patients with a circuit including epicardial structures, 6 patients treated with ethanol infusion in the vein of Marshall did not show any AT recurrence, although 8 of 15 (53.3%) treated with radiofrequency showed AT recurrence (
P
=0.04).
Conclusions:
Although high-resolution mapping may lead to correct diagnosis and appropriate ablation in the first procedure, the recurrence rate is still high. The main mechanism of atrial fibrillation ablation–related AT is the recurrence of PMF and RMAT or non-AMAT different from the first procedure. Epicardial structures (eg, coronary sinus/vein of Marshall system) are often involved, and ethanol infusion in the vein of Marshall may be an additional treatment.
Collapse
Affiliation(s)
- Masateru Takigawa
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
- Heart Rhythm Center, Tokyo Medical and Dental University, Japan (M.T.)
| | - Nicolas Derval
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Claire A. Martin
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
- Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom (C.A.M.)
| | - Konstantinos Vlachos
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Arnaud Denis
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Yosuke Nakatani
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Takeshi Kitamura
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Ghassen Cheniti
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Felix Bourier
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Anna Lam
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Ruairidh Martin
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
- Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (R.M.)
| | - Antonio Frontera
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Nathaniel Thompson
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Grégoire Massoullié
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Michael Wolf
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - William Escande
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Clémentine André
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Li-jun Zeng
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | | | - Josselin Duchateau
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Thomas Pambrun
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Frederic Sacher
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Hubert Cochet
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Mélèze Hocini
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Michel Haïssaguerre
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| | - Pierre Jaïs
- Cardiac Electrophysiology and Cardiac Stimulation Team, Bordeaux University Hospital (CHU), CHU Bordeaux, IHU Lyric, Université de Bordeaux, France (M.T., N.D., C.A.M., K.V., A.D., Y.N., T.K., G.C., F.B., A.L., R.M., A.F., N.T., G.M., M.W., W.E., C.A., L.-j.Z., J.D., T.P., F.S., H.C., M. Hocini, M. Haïssaguerre, P.J.)
| |
Collapse
|
22
|
Piątek-Koziej K, Hołda J, Bolechała F, Kopacz P, Koziej M, Chłosta M, Tyrak K, Jasińska KA, Hołda MK. Topographic characteristics of the left atrial medial isthmus. PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2019; 42:1579-1585. [PMID: 31691995 DOI: 10.1111/pace.13834] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 10/22/2019] [Accepted: 11/02/2019] [Indexed: 11/29/2022]
Abstract
BACKGROUND The purpose of this study was to provide detailed topography of the left atrial medial isthmus (situated between the right inferior pulmonary vein ostium and the medial part of the mitral annulus). METHODS Two hundred human hearts (Caucasian, 22.5% females, 48.7 ± 4.9 years old) were investigated. RESULTS The mean length of the medial isthmus was 42.4 ± 8.6 mm. Additionally, the medial isthmus line was divided by the oval fossa into three sections with equal mean lengths (upper: 14.2 ± 7.2 vs middle: 14.1 ± 6.1 vs lower: 14.9 ± 4.6 mm; P > .05). The left upper section of the atrial wall was thinner than the lower section (2.5 ± 1.1 vs 3.4 ± 1.6 mm; P < .0001). This study noted three separate spatial arrangements of the isthmus line. Type I (54.5%) had an oval fossa located outside the isthmus line; type II (32.5%) had an oval fossa crossed by the isthmus line, and type III (13.0%) had an oval fossa rim located tangentially to the isthmus line. In 68.5% of the examined specimens, the isthmus area had a smooth surface. Conversely, the remaining 31.5% had additional structures within its borders such as diverticula, recesses, and tissue bridges. CONCLUSION This study is the first to describe the morphometric and topographical features of the left atrial medial isthmus. Interventions within the medial isthmus line should be performed cautiously, especially when they are transected by the oval fossa (32.5%). Careful navigation of the area is also recommended due to the possibility of existent additional structures. The latter could lead to catheter entrapment during ablation procedures.
Collapse
Affiliation(s)
- Katarzyna Piątek-Koziej
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| | - Jakub Hołda
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| | - Filip Bolechała
- Department of Forensic Medicine, Jagiellonian University Medical College, Cracow, Poland
| | - Paweł Kopacz
- Department of Forensic Medicine, Jagiellonian University Medical College, Cracow, Poland
| | - Mateusz Koziej
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| | - Marcin Chłosta
- Comenius University in Bratislava, Jessenius Faculty of Medicine, Martin, Czech Republic
| | - Kamil Tyrak
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| | - Katarzyna A Jasińska
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| | - Mateusz K Hołda
- HEART-Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland
| |
Collapse
|
23
|
Wolf M, El Haddad M, Fedida J, Taghji P, Van Beeumen K, Strisciuglio T, De Pooter J, Lepièce C, Vandekerckhove Y, Tavernier R, Duytschaever M, Knecht S. Evaluation of left atrial linear ablation using contiguous and optimized radiofrequency lesions: the ALINE study. Europace 2019; 20:f401-f409. [PMID: 29325036 DOI: 10.1093/europace/eux350] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 11/01/2017] [Indexed: 11/13/2022] Open
Abstract
Aims Achieving block across linear lesions is challenging. We prospectively evaluated radiofrequency (RF) linear ablation at the roof and mitral isthmus (MI) using point-by-point contiguous and optimized RF lesions. Methods and results Forty-one consecutive patients with symptomatic persistent AF underwent stepwise contact force (CF)-guided catheter ablation during ongoing AF. A single linear set of RF lesions was delivered at the roof and posterior MI according to the 'Atrial LINEar' (ALINE) criteria, i.e. point-by-point RF delivery (up to 35 W) respecting strict criteria of contiguity (inter-lesion distance ≤ 6 mm) and indirect lesion depth assessment (ablation index ≥550). We assessed the incidence of bidirectional block across both lines only after restoration of sinus rhythm. After a median RF time of 7 min [interquartile range (IQR) 5-9], first-pass block across roof lines was observed in 38 of 41 (93%) patients. Final bidirectional roof block was achieved in 40 of 41 (98%) patients. First-pass block was observed in 8 of 35 (23%) MI lines, after a median RF time of 8 min (IQR 7-12). Additional endo- and epicardial (54% of patients) RF applications resulted in final bidirectional MI block in 28 of 35 (80%) patients. During a median follow-up of 396 (IQR 310-442) days, 12 patients underwent repeat procedures, with conduction recovery in 4 of 12 and 5 of 10 previously blocked roof lines and MI lines, respectively. No complications occurred. Conclusion Anatomical linear ablation using contiguous and optimized RF lesions results in a high rate of first-pass block at the roof but not at the MI. Due to its complex 3D architecture, the MI frequently requires additional endo- and epicardial RF lesions to be blocked.
Collapse
Affiliation(s)
- Michael Wolf
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Milad El Haddad
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Joël Fedida
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Philippe Taghji
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Katarina Van Beeumen
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Teresa Strisciuglio
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Jan De Pooter
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Caroline Lepièce
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Yves Vandekerckhove
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - René Tavernier
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Mattias Duytschaever
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| | - Sébastien Knecht
- Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
| |
Collapse
|
24
|
Hamoud NS, Abrich VA, Shen WK, Mulpuru SK, Srivathsan K. Achieving durable mitral isthmus block: Challenges, pitfalls, and methods of assessment. J Cardiovasc Electrophysiol 2019; 30:1679-1687. [PMID: 31332867 DOI: 10.1111/jce.14079] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 06/28/2019] [Accepted: 07/11/2019] [Indexed: 10/26/2022]
Abstract
BACKGROUND AND OBJECTIVES Macroreentrant atrial tachycardias often occur following atrial fibrillation ablation, most commonly due to nontransmural lesions in prior ablation lines. Perimitral atrial flutter is one such arrhythmia which requires ablation of the mitral isthmus. Our objectives were to review the literature regarding ablation of the mitral isthmus and to provide our approach for assessment of mitral isthmus block. METHODS We review anatomical considerations, ablation strategies, and assessment of conduction block across the mitral isthmus, which is subject to several pitfalls. Activation sequence and spatial differential pacing techniques are discussed for assessment of both endocardial and epicardial bidirectional mitral isthmus block. RESULTS Traditional methods for verifying mitral isthmus block include spatial differential pacing, activation mapping, and identification of double potentials. Up to 70% of cases require additional ablation in the coronary sinus (CS) to achieve transmural block. Interpretation of transmural block is subject to six pitfalls involving pacing output, differentiation of endocardial left atrial recordings from epicardial CS recordings, identification of a slowly conducting gap in the line, and catheter positioning during spatial differential pacing. Interpretation of unipolar electrograms can identify nontransmural lesions. We employ a combined epicardial and endocardial assessment of mitral isthmus block, which involves using a CS catheter for epicardial recording and a duodecapolar Halo catheter positioned around the mitral annulus for endocardial recording. CONCLUSIONS The assessment of transmural mitral isthmus block can be challenging. Placement of an endocardial mapping catheter around the mitral annulus can provide a precise assessment of conduction across the mitral isthmus.
Collapse
Affiliation(s)
- Naktal S Hamoud
- Department of Cardiovascular Diseases, Mayo Clinic Arizona, Phoenix, Arizona
| | - Victor A Abrich
- Department of Cardiovascular Diseases, Mayo Clinic Arizona, Phoenix, Arizona
| | - Win-Kuang Shen
- Department of Cardiovascular Diseases, Mayo Clinic Arizona, Phoenix, Arizona
| | - Siva K Mulpuru
- Department of Cardiovascular Diseases, Mayo Clinic Rochester, Rochester, Minnesota
| | | |
Collapse
|
25
|
Fujisawa T, Kimura T, Nakajima K, Nishiyama T, Katsumata Y, Aizawa Y, Fukuda K, Takatsuki S. Importance of the vein of Marshall involvement in mitral isthmus ablation. Pacing Clin Electrophysiol 2019; 42:617-624. [PMID: 30779354 DOI: 10.1111/pace.13640] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Revised: 01/11/2019] [Accepted: 02/02/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND Epicardiac conduction via the vein of Marshall (VOM) can bypass the mitral isthmus (MI) line, making MI ablation difficult. This study aimed to assess the contribution of the VOM in achieving MI conduction block. METHODS This study included 143 consecutive patients with nonparoxysmal atrial fibrillation who underwent initial MI ablation. They were retrospectively classified into two groups, a VOM-guided group (n = 28) and a conventional group (n = 115), according to the use of a 2-Fr electrode catheter inserted in the VOM. The acute success rate of achieving MI block and the ablation data were assessed. When the bidirectional block was verified exclusively in the VOM or coronary sinus (CS) electrodes, we defined it as a pseudo MI block. In the VOM-guided group, we ascertained the complete MI block, verified both in the VOM and CS electrodes. RESULTS In the VOM-guided group, the pseudoblock was observed in 33.3% of the patients during MI ablation. With significantly less radiofrequency energy (19 322.6 ± 11 352.8 vs 25 389.3 ± 19 951.9, P = 0.04), we achieved a similar level of success rate in MI ablation in the VOM-guided group (96.4% vs 91.3%, P = 0.36). Notably, after achieving complete MI block, atrial burst pacing induced two perimitral flutters in the VOM-guided group, which were successfully terminated by the additional radiofrequency application. CONCLUSIONS Assessment of electrical conduction through the VOM could clarify the existence of a pseudo MI conduction block. However, the existence of a slow conduction through the MI could be detected only after induction of perimitral atrial tachycardia with atrial programmed stimulation.
Collapse
Affiliation(s)
- Taishi Fujisawa
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | - Takehiro Kimura
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | - Kazuaki Nakajima
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | - Takahiko Nishiyama
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | | | - Yoshiyasu Aizawa
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | - Keiichi Fukuda
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| | - Seiji Takatsuki
- Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
| |
Collapse
|
26
|
Chen S, Zhou G, Lu X, Wei Y, Xu J, Cai L, Wu X, Liu S, Po SS. The importance of identifying conduction breakthrough sites across the mitral isthmus by elaborate mapping for mitral isthmus linear ablation. Europace 2019; 21:950-960. [PMID: 30715302 DOI: 10.1093/europace/euy327] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Accepted: 01/21/2019] [Indexed: 11/13/2022] Open
Affiliation(s)
- Songwen Chen
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Genqing Zhou
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Xiaofeng Lu
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Yong Wei
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Juan Xu
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Lidong Cai
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Xiaoyu Wu
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Shaowen Liu
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, No 100, Haining Road, Shanghai, China
| | - Sunny S Po
- Section of Cardiovascular Diseases, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| |
Collapse
|
27
|
Hołda MK, Hołda J, Strona M, Koziej M, Klimek-Piotrowska W. Blood Vessels and Myocardial Thickness within the Left Atrial Appendage Isthmus Line. Clin Anat 2018; 31:1024-1030. [DOI: 10.1002/ca.23242] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 06/13/2018] [Accepted: 06/23/2018] [Indexed: 11/08/2022]
Affiliation(s)
- Mateusz K. Hołda
- HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy; Jagiellonian University Medical College; Cracow Poland
| | - Jakub Hołda
- HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy; Jagiellonian University Medical College; Cracow Poland
| | - Marcin Strona
- Department of Forensic Medicine; Jagiellonian University Medical College; Cracow Poland
| | - Mateusz Koziej
- HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy; Jagiellonian University Medical College; Cracow Poland
| | - Wiesława Klimek-Piotrowska
- HEART - Heart Embryology and Anatomy Research Team, Department of Anatomy; Jagiellonian University Medical College; Cracow Poland
| |
Collapse
|
28
|
|
29
|
Liu Y, Shehata M, Wang X. Alternative Approach for Ablation of the Mitral Isthmus. Circ Arrhythm Electrophysiol 2017; 10:CIRCEP.117.005814. [PMID: 29018168 DOI: 10.1161/circep.117.005814] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Accepted: 08/16/2017] [Indexed: 11/16/2022]
Affiliation(s)
- Yang Liu
- From the Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA (Y.L., M.S., X.W.); and Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (Y.L.)
| | - Michael Shehata
- From the Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA (Y.L., M.S., X.W.); and Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (Y.L.)
| | - Xunzhang Wang
- From the Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA (Y.L., M.S., X.W.); and Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (Y.L.).
| |
Collapse
|
30
|
Maurer T, Metzner A, Ho SY, Wohlmuth P, Reißmann B, Heeger C, Lemes C, Hayashi K, Saguner AM, Riedl J, Sohns C, Mathew S, Kuck KH, Wissner E, Ouyang F. Catheter Ablation of the Superolateral Mitral Isthmus Line. Circ Arrhythm Electrophysiol 2017; 10:CIRCEP.117.005191. [DOI: 10.1161/circep.117.005191] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2017] [Accepted: 08/23/2017] [Indexed: 12/20/2022]
Affiliation(s)
- Tilman Maurer
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Andreas Metzner
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - S. Yen Ho
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Peter Wohlmuth
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Bruno Reißmann
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Christian Heeger
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Christine Lemes
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Kentaro Hayashi
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Ardan M. Saguner
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Johannes Riedl
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Christian Sohns
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Shibu Mathew
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Karl-Heinz Kuck
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Erik Wissner
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| | - Feifan Ouyang
- From the Department of Cardiology, Asklepios-Klinik St Georg, Hamburg, Germany (T.M., A.M., B.R., C.H., C.L., K.H., A.M.S., J.R., C.S., S.M., K.-H.K., F.O.); Royal Brompton Hospital and Harefield NHS Trust, London, United Kingdom (S.Y.H.); Asklepios Proresearch, Hamburg, Germany (P.W.); and Division of Cardiology, University of Illinois at Chicago (E.W.)
| |
Collapse
|
31
|
Mitral isthmus ablation using a circular mapping catheter positioned in the left atrial appendage as a reference for conduction block. Oncotarget 2017; 8:52724-52734. [PMID: 28881765 PMCID: PMC5581064 DOI: 10.18632/oncotarget.17092] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2017] [Accepted: 03/11/2017] [Indexed: 12/02/2022] Open
Abstract
Background For perimitral atrial flutter (PMFL) developing after catheter ablation of atrial fibrillation (AF), to create a complete conduction block at the mitral isthmus (MI) is mandatory to terminate it, however, it is still challenging. Methods This study consisted of 80 patients (74 male, 61 ± 8.1 years) undergoing MI ablation. After a circular mapping catheter was positioned at the neck of the left atrial appendage (LAA), the MI ablation was performed on the MI line just below the LAA neck targeting the earliest activation recording site of the LAA catheter during pacing from the coronary sinus (CS). When ablation during CS pacing was not successful, an RF delivery during LAA pacing was applied targeting the earliest activation site just below the MI line. If the endocardial approach failed, an RF application inside the CS was attempted. Results With the endocardial approach, acute success was achieved in 51/80 patients (64%). Additional epicardial ablation from the CS was performed in 26/29 (90%) endocardially unsuccessful patients and conduction block at the MI was achieved in 21/26 (81%). Overall, complete conduction block at the MI was achieved in 72/80 patients (90%). At a mean follow-up of 16 ± 6 months, 20 patients (25%) had recurrence of atrial arrhythmias (AT: 12, AF: 8), and 10 (AT: 7, AF : 3) underwent a second procedure in which an LMI block line was completed in 3 (33%). PMFL was diagnosed in 6 out of 7 AT patients. No complications were observed. Conclusions Creating linear lesions just beneath the neck of the LAA was highly successful under the guidance of a circular mapping catheter in the LAA using a steerable sheath. An RF application from the CS was needed in less than half of the cases.
Collapse
|
32
|
Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Sunaga A, Tsujimura T, Matsuda Y, Mano T. Association Between Local Bipolar Voltage and Conduction Gap Along the Left Atrial Linear Ablation Lesion in Patients With Atrial Fibrillation. Am J Cardiol 2017; 120:408-413. [PMID: 28577751 DOI: 10.1016/j.amjcard.2017.04.042] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 04/19/2017] [Accepted: 04/19/2017] [Indexed: 11/28/2022]
Abstract
A bipolar voltage reflects a thick musculature where formation of a transmural lesion may be hard to achieve. The purpose of this study was to explore the association between local bipolar voltage and conduction gap in patients with persistent atrial fibrillation (AF) who underwent atrial roof or septal linear ablation. This prospective observational study included 42 and 36 consecutive patients with persistent AF who underwent roof or septal linear ablations, respectively. After pulmonary vein isolation, left atrial linear ablations were performed, and conduction gap sites were identified and ablated after first-touch radiofrequency application. Conduction gap(s) after the first-touch roof and septal linear ablation were observed in 13 (32%) and 19 patients (53%), respectively. Roof and septal area voltages were higher in patients with conduction gap(s) than in those without (roof, 1.23 ± 0.77 vs 0.73 ± 0.42 mV, p = 0.010; septal, 0.96 ± 0.43 vs 0.54 ± 0.18 mV, p = 0.001). Trisected regional analyses revealed that the voltage was higher at the region with a conduction gap than at the region without. Complete conduction block across the roof and septal lines was not achieved in 3 (7%) and 6 patients (17%), respectively. Patients in whom a linear conduction block could not be achieved demonstrated higher ablation area voltage than those with a successful conduction block (roof, 1.91 ± 0.74 vs 0.81 ± 0.51 mV, p = 0.001; septal, 1.15 ± 0.56 vs 0.69 ± 0.31 mV, p = 0.006). In conclusion, a high regional bipolar voltage predicts failure to achieve conduction block after left atrial roof or septal linear ablation. In addition, the conduction gap was located at the preserved voltage area.
Collapse
Affiliation(s)
- Masaharu Masuda
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan.
| | - Masashi Fujita
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Osamu Iida
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Shin Okamoto
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Takayuki Ishihara
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Kiyonori Nanto
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Takashi Kanda
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Akihiro Sunaga
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Takuya Tsujimura
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Yasuhiro Matsuda
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| | - Toshiaki Mano
- Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan
| |
Collapse
|
33
|
Yu J, Chen K, Yang B, Zhang F, Ju W, Chen H, Yang G, Li M, Wang B, Gu K, Ouyang F, Ho SY, Po S, Chen M. Peri-mitral atrial flutter: personalized ablation strategy based on arrhythmogenic substrate. Europace 2017; 20:835-842. [PMID: 28340110 DOI: 10.1093/europace/euw431] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Accepted: 12/14/2016] [Indexed: 11/12/2022] Open
Affiliation(s)
- Jinbo Yu
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Kai Chen
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Bing Yang
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Fengxiang Zhang
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Weizhu Ju
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Hongwu Chen
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Gang Yang
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Mingfang Li
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Benqi Wang
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Kai Gu
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| | - Feifan Ouyang
- Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Germany
| | - Siew Yen Ho
- Cardiac Morphology Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK
| | - Sunny Po
- Section of Cardiovascular Diseases and Heart Rhythm Institute, University of Oklahoma Health Sciences Center, 1200 Everett Drive, TCH 6E103, Oklahoma City, OK, 73104, USA
| | - Minglong Chen
- Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
| |
Collapse
|
34
|
Hołda MK, Koziej M, Hołda J, Tyrak K, Piątek K, Krawczyk-Ożóg A, Klimek-Piotrowska W. Spatial relationship of blood vessels within the mitral isthmus line. Europace 2017; 20:706-711. [DOI: 10.1093/europace/euw423] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Accepted: 12/01/2016] [Indexed: 11/13/2022] Open
Affiliation(s)
- Mateusz K Hołda
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| | - Mateusz Koziej
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| | - Jakub Hołda
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| | - Kamil Tyrak
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| | - Katarzyna Piątek
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| | - Agata Krawczyk-Ożóg
- 2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Kopernika 19, 31-501 Krakow, Poland
| | - Wiesława Klimek-Piotrowska
- Department of Anatomy, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
- HEART—Heart Embryology and Anatomy Research Team, Jagiellonian University Medical College, Cracow, Kopernika 12, 31-034 Krakow, Poland
| |
Collapse
|
35
|
LEE JIHYUN, NAM GIBYOUNG, KIM MINSU, HWANG YOUMI, HWANG JONGMIN, KIM JUN, CHOI KEEJOON, KIM YOUHO. Radiofrequency Catheter Ablation Targeting the Vein of Marshall in Difficult Mitral Isthmus Ablation or Pulmonary Vein Isolation. J Cardiovasc Electrophysiol 2017; 28:386-393. [DOI: 10.1111/jce.13161] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2016] [Revised: 11/04/2016] [Accepted: 12/16/2016] [Indexed: 12/01/2022]
Affiliation(s)
- JI HYUN LEE
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - GI-BYOUNG NAM
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - MINSU KIM
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - YOU MI HWANG
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - JONGMIN HWANG
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - JUN KIM
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - KEE-JOON CHOI
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - YOU-HO KIM
- Heart Institute, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| |
Collapse
|
36
|
Laţcu DG, Bun SS, Viera F, Delassi T, El Jamili M, Al Amoura A, Saoudi N. Selection of Critical Isthmus in Scar-Related Atrial Tachycardia Using a New Automated Ultrahigh Resolution Mapping System. Circ Arrhythm Electrophysiol 2017; 10:CIRCEP.116.004510. [DOI: 10.1161/circep.116.004510] [Citation(s) in RCA: 87] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 11/11/2016] [Indexed: 11/16/2022]
Abstract
Background—
Accurate activation mapping of reentrant scar-related atrial tachycardias (AT) allows efficient radiofrequency ablation by targeting the critical isthmus (CI). We aimed to assess the electrophysiological properties of CI channels during mapping with the IntellaMap Orion basket and the Rhythmia system.
Methods and Results—
We prospectively studied 33 AT (post– atrial fibrillation ablation or surgical mitral valve repair). The noise of bipolar electrogram (EGM) was systematically measured at 10 prespecified sites, as well as on a standard catheter and on the surface ECG. Bipolar EGM of CI regions were analyzed for amplitude, duration, and conduction velocity. The isthmus region to be targeted was chosen based solely on propagation. For each AT, 25 684±14 276 EGMs were automatically annotated. Noise of the Orion EGM was 0.011±0.004 mV, lower than that of a standard catheter (0.016±0.019) and surface ECG (0.02±0.01;
P
<0.05). For reentrant AT, within the CI, bipolar EGM amplitude (0.08±0.11 mV) and conduction velocity (0.27±0.19 m/s) were lower than those orthodromically before (0.62±0.93 mV; 1±0.49 m/s) and after (0.80±1.59 mV; 1±0.73 m/s) the isthmus (
P
<0.001 for all). In 97% of AT, ablation at the CI resulted in AT termination. No complications occurred.
Conclusions—
This new automated ultrahigh resolution mapping system produces low noise and allows accurate diagnosis of AT circuits. CI on reentrant scar-related AT showed much lower EGM amplitude with a significantly slower conduction velocity than the surrounding parts of the circuit. Ablation of the areas of slow conduction resulted in a high acute success.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Nadir Saoudi
- From the Centre Hospitalier Princesse Grace, Monaco
| |
Collapse
|